Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
The Lancet. Infectious Diseases
|
April 28, 2009
Infection control in the management of highly pathogenic infectious diseases: consensus of the European Network of Infectious Disease
Philippe Brouqui, Vincenzo Puro, Francesco M Fusco, et al.
Viral Immunology
|
May 4, 2023
Does COVID-19 Vaccination with BNT162b2 Influence HIV-Related Immunological and Virological Markers? Data from 235 Persons Living with HIV at Cotugno Hospital, Naples, Italy: Immune Response After Second and Third Doses, and Influence on Immunovirological Markers
Francesco M Fusco, Maria Aurora Carleo, Nadia Sangiovanni, et al.
Cell Reports. Medicine
|
June 14, 2023
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial
Stefania Capone, Francesco M Fusco, Stefano Milleri, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
September 11, 2020
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study
Augusto Di Castelnuovo, Marialaura Bonaccio, Simona Costanzo, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
The Lancet. Infectious Diseases
|
April 28, 2009
Infection control in the management of highly pathogenic infectious diseases: consensus of the European Network of Infectious Disease
Philippe Brouqui, Vincenzo Puro, Francesco M Fusco, et al.
Viral Immunology
|
May 4, 2023
Does COVID-19 Vaccination with BNT162b2 Influence HIV-Related Immunological and Virological Markers? Data from 235 Persons Living with HIV at Cotugno Hospital, Naples, Italy: Immune Response After Second and Third Doses, and Influence on Immunovirological Markers
Francesco M Fusco, Maria Aurora Carleo, Nadia Sangiovanni, et al.
Cell Reports. Medicine
|
June 14, 2023
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial
Stefania Capone, Francesco M Fusco, Stefano Milleri, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
September 11, 2020
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study
Augusto Di Castelnuovo, Marialaura Bonaccio, Simona Costanzo, et al.
Page
of 2